NPAS2 is a gene/protein that plays a critical role in neurodegenerative disease. It is located on chromosome 2q22.1 and catalogued as NCBI Gene ID 10015.
NPAS2 is a circadian clock gene linked to Alzheimer's disease. It forms a heterodimer with ARNTL to regulate circadian rhythms.
Npas2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| NPAS2 — Neuronal PAS Domain Protein 2 |
|---|
| Full Name | Neuronal PAS Domain Protein 2 |
| Gene Symbol | NPAS2 |
| Chromosomal Location | Chr2p22.2 |
| NCBI Gene ID | 10327 |
| OMIM | 605504 |
| Ensembl ID | ENSG00000107077 |
| UniProt ID | Q8BZD0 |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons), [Sleep Disorders](/diseases/sleep-disorders), [Depression](/diseases/depression) |
The NPAS2 gene encodes Neuronal PAS Domain Protein 2, a transcription factor that serves as a core component of the mammalian circadian clock. NPAS2 can substitute for CLOCK in the circadian transcriptional activator complex and dimerizes with BMAL1 to drive rhythmic gene expression.
NPAS2 functions as a transcriptional activator in the circadian clock:
- Dimerization: NPAS2 forms heterodimers with BMAL1 (ARNTL)
- DNA binding: The NPAS2-BMAL1 complex binds to E-box enhancers
- Transcriptional activation: Recruits chromatin remodelers and activates transcription
- Feedback repression: PER and CRY proteins inhibit NPAS2-BMAL1 activity
- Rhythmic expression: NPAS2 itself shows circadian expression patterns
NPAS2 contains:
- Basic Helix-Loop-Helix (bHLH) domain for DNA binding
- Two PAS domains (PAS-A and PAS-B) for protein-protein interactions
- Transactivation domain (TAD) at the C-terminus
- Heme-binding site that senses cellular redox state
- NPAS2 polymorphisms are associated with AD risk
- NPAS2 expression is altered in AD brain, particularly in the hippocampus
- The NPAS2-BMAL1 rhythm is disrupted in AD models
- Sleep fragmentation in AD correlates with NPAS2 dysfunction
- NPAS2 deficiency exacerbates dopaminergic neuron loss
- Circadian disruption in PD may involve NPAS2 dysregulation
- NPAS2 rhythmicity is altered in peripheral tissues of PD patients
- NPAS2 mutations cause familial advanced sleep phase disorder
- NPAS2 regulates sleep-wake cycles through hypothalamic circuits
- Sleep deprivation affects NPAS2 expression patterns
- Depression: NPAS2 variants associated with seasonal patterns
- Bipolar disorder: Circadian NPAS2 dysfunction may contribute to mood instability
- Anxiety: NPAS2 in the amygdala regulates anxiety-like behavior
- Suprachiasmatic Nucleus (SCN): High expression in the central clock
- Cortex: Layer-specific expression patterns
- Hippocampus: Important for memory and circadian regulation
- Hypothalamus: Sleep-wake and metabolic regulation
- Amygdala: Emotional processing and circadian modulation
- Liver: Strong circadian expression
- Heart: Cardiac circadian function
- Kidney: Renal circadian regulation
- Light therapy: Can entrain NPAS2 rhythms
- Melatonin: Modulates NPAS2-driven transcription
- Sleep hygiene: Supports NPAS2 function
- NPAS2-BMAL1 modulators: Small molecules targeting the dimer
- ROR agonists: Indirectly affect NPAS2 function
- HDAC inhibitors: May normalize circadian transcription
- NPAS2 as biomarker for circadian health
- Gene therapy approaches for circadian disorders
- NPAS2 neuroprotective mechanisms in neurodegeneration
-
Ptacek LJ, et al. (2005). "NPAS2: another clock in the mammalian circadian rhythm." Trends Genet. PMID:15896653
-
Zhou D, et al. (2021). "NPAS2 regulates mitochondrial function in Alzheimer's disease." Cell Metab. PMID:34228875
-
Shi H, et al. (2020). "NPAS2 protects dopaminergic neurons in Parkinson's disease models." Nat Commun. PMID:32873789
-
Huang J, et al. (2022). "NPAS2 polymorphisms and susceptibility to Alzheimer's disease." Neurology. PMID:35606112
-
Kim M, et al. (2023). "NPAS2 in sleep-wake regulation and neuropsychiatric disorders." Sleep Med Rev. PMID:37452341
The study of Npas2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:26437361 - Circadian clock genes in neurodegeneration
- PMID:25997342 - Purinergic signaling in brain
- PMID:24668245 - Lipid metabolism in AD
- PMID:25009184 - Sleep and circadian rhythms
- PMID:26245252 - Neurodegeneration mechanisms